Vanquish Oncology’s small molecule could trigger selective cancer cell death
The drug works by activating a protein called procaspase-3 that triggers cell death. Vanquish's small molecule therefore is aimed at kicking off the process of apoptosis in cancer cells, ultimately killing them.